Huge funding injection for varicose vein clinic

Veincentre is set to expand

A UK-based provider of treatment for varicose veins is planning to expand after securing investment from Palatine Private Equity and a seven-figure refinance deal with Santander.

Veincentre, which operates eight sites across the UK in addition to its premises in Nottingham, wants to expand its number of clinics after receiving backing from Palatine’s Impact Fund.

The company will look to launch a Liverpool site in Q1 and a further two clinics before the end of the year.

David West, medical director at Veincentre, said: “Our ambition is to provide an affordable service to as many patients as possible, and a key part of this is making sure we have a presence in each of the UK’s major cities and regions. Palatine’s investment, along with the support from the team, is helping us realise that vision, and this additional funding will facilitate further expansion.”

Palatine’s Impact Fund targets companies with a positive social and/or environmental impact alongside industry-standard returns. Beth Houghton, head of the Impact Fund, led the Veincentre deal with support from James Gregson and James Painter.

Painter, investment director at Palatine, said: “Veincentre serves as another great example of Palatine’s strong track record of executing rollout strategies, along with Gusto, The Alchemist, Estio Training and Trade Skills 4U. We are pleased to have opened two new clinics in the first six months of our investment and look forward to supporting the management team in growing the portfolio of clinics further.”

Click here to sign up to receive our new South West business news...
Close